Hypocholesterolemic effect of sericin-derived oligopeptides in high-cholesterol fed rats
- 354 Downloads
The beneficial effect of cholesterol-lowering proteins and/or peptides derived from various dietary sources is continuously reported. A non-dietary protein from silk cocoon, sericin, has also demonstrated cholesterol-lowering activity. A sericin hydrolysate prepared by enzymatic hydrolysis was also expected to posses this effect. The present study was aimed at investigating the cholesterol-lowering effect of sericin peptides, so called “sericin-derived oligopeptides” (SDO) both in vivo and in vitro. The results showed that SDO at all three doses tested (10 mg kg−1 day−1, 50 mg kg−1 day−1, and 200 mg kg−1 day−1) suppressed serum total and non-HDL cholesterol levels in rats fed a high-cholesterol diet. Triglyceride and HDL-cholesterol levels were not significantly changed among all groups. The fecal contents of bile acids and cholesterol did not differ among high-cholesterol fed rats. SDO dose-dependently reduced cholesterol solubility in lipid micelles, and inhibited cholesterol uptake in monolayer Caco-2 cells. SDO also effectively bound to all three types of bile salts including taurocholate, deoxytaurocholate, and glycodeoxycholate. Direct interaction with bile acids of SDO may disrupt micellar cholesterol solubility, and subsequently reduce the absorption of dietary cholesterol in intestines. Taking all data together, SDO or sericin peptides exhibit a beneficial effect on blood cholesterol levels and could be potentially used as a health-promoting dietary supplement or nutraceutical product.
KeywordsSericin Hypocholesterolemic effect Cholesterol Protein hydrolysate Bile acid binding Micellar solubility
The authors thank Dr. Norman Scholfield for manuscript preparation. This research project was supported by Agricultural Research Development Agency (ARDA), and the Center of Excellence for Innovation in Chemistry (PERCH-CIC).
Compliances with ethical standards
Conflict of interest
Phakhamon Lapphanichayakool declares no conflict of interest. The sponsor (ARDA), Manote Sutheerawattananonda, and Nanteetip Limpeanchob hold a patent WO2013/032411A1 in title silk-based bioactive oligopeptide compositions and manufacturing process thereof.
- 4.Wergedahl H, Liaset B, Gudbrandsen OA, Lied E, Espe M, Muna Z, Mork S, Berge RK (2004) Fish protein hydrolysate reduces plasma total cholesterol, increases the proportion of HDL cholesterol, and lowers acyl-CoA:cholesterol acyltransferase activity in liver of Zucker rats. J Nutr 134:1320–1327CrossRefPubMedGoogle Scholar
- 15.Hosomi R, Fukao M, Fukunaga K, Okuno M, Yagita R, Kanda S, Nishiyama T, Yoshida M (2010) Effect of fish protein and peptides on lipid absorption in rats. Trace Nutr Res 27:21–27Google Scholar
- 17.Gudbrandsen OA, Wergedahl H, Liaset B, Espe M, Berge RK (2005) Dietary proteins with high isoflavone content or low methionine-glycine and lysine-arginine ratios are hypocholesterolaemic and lower the plasma homocysteine level in male Zucker fa/fa rats. Br J Nutr 94:321–330CrossRefPubMedGoogle Scholar
- 21.Kirana C, Rogers PF, Bennett LE, Abeywardena MY, Patten GS (2005) Naturally derived micelles for rapid in vitro screening of potential cholesterol-lowering bioactives. J Agric Food Chem 53:4623–4627Google Scholar
- 22.Porter JL, Fordtran JS, Santa Ana CA, Emmett M, Hagey LR, Macdonald EA, Hofmann AF (2003) Accurate enzymatic measurement of fecal bile acids in patients with malabsorption. J Lab Clin Med 141:411–418Google Scholar